You Position: Home > Paper
沙美特罗/丙酸氟替卡松联合孟鲁司特治疗慢性中度持续支气管哮喘临床疗效观察
( views:178, downloads:0 )
- Author:
- No author available
- Journal Title:
- SECTION OF RESPIRATORY SYSTEM FOREIGN MEDICAL SCIENCES
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1673-436X.2005.04.025
- Key Word:
- No keyword available
Abstract： @@ 白三烯是一种脂类介质,是哮喘发病涉及的主要炎性介质.其半胱胺酰白三烯(CysLTs)是强有力的支气管收缩剂和嗜酸粒细胞(EOS)细胞趋化因子,而白三烯拮抗剂在全球哮喘防治创议(GINA)中的地位已被确立.本研究对2003年来我院就治的265例慢性中度持续支气管哮喘,随机分为采用规范治疗同时加用白三烯拮抗剂孟鲁司特(顺尔宁)治疗和不加用顺尔宁治疗两组,对其临床疗效、肺功能指标变化、炎性介质变化进行评价.
- [1]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南（支气管哮喘的定义、诊断、治疗及教育和管理方案）[J].2003,(3).
- [2]Cesar Villaran,Shane J. O’Neill,Arthur Helbling,etc.Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction[J].1999,104(3).
- [3]Leff JA,Kundu S,Godard P,etc.Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.[J].1999,319(7202).